Mark J. Gergen - Feb 1, 2024 Form 4 Insider Report for Poseida Therapeutics, Inc. (PSTX)

Role
Executive Chairman, Director
Signature
/s/ Harry J.Leonhardt, Attorney-in-Fact
Stock symbol
PSTX
Transactions as of
Feb 1, 2024
Transactions value $
-$160,822
Form type
4
Date filed
2/2/2024, 08:51 PM
Previous filing
Jan 4, 2024
Next filing
Mar 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PSTX Common Stock Tax liability -$161K -47.2K -6.44% $3.41 685K Feb 1, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on February 1, 2022.